Tillman Gerngross

money bank piggybank

Biotech

Triveni raises $92M for I&I pipeline after Modify, Amagma merger

Triveni Bio, the product of a merger between Amagma and Modify, has unveiled with $92 million and a preclinical I&I antibody program.

Gabrielle Masson Oct 26, 2023 11:27am

Resist resistance fight against cancer arrows out tumor immunotherapy

Adagio still hopes to build omicron offense for COVID-19 therapy

May 13, 2022 10:31am

Businessperson walking out

Adimab swaps scientist for lawyer as CEO

May 10, 2022 9:22am